Typicality: | 0.444 |
Saliency: | 0.455 |
from an ebola protein | 3 | other |
in germany | 2 | location |
to help prevent people | 2 | purpose |
vaccine → be developed by → glaxosmithkline | 32 |
vaccine → be manufactured by → glaxosmithkline | 20 |
vaccine → be produced by → glaxosmithkline | 16 |
vaccine → be made by → glaxosmithkline | 11 |
vaccine → made by → glaxosmithkline | 3 |
vaccine → developed by → british drugmaker glaxosmithkline | 3 |
negative | neutral | positive |
0.129 | 0.683 | 0.189 |
Raw frequency | 85 |
Normalized frequency | 0.455 |
Modifier score | 0.500 |
Perplexity | 16.469 |